FSCN1 and colonic neoplasm: It was reported that FSCN1 transcriptional activity is controlled by the promoter region (−219/+114); in breast and colon cancer, CREB and aryl hydrocarbon receptors (AhRs) bind with the −219/+114 promoter region [77].